The White Rose UK – Defend Freedom – Defend Humanity

FDA approves Moderna's first-ever mRNA flu shot despite 75.3% adverse reaction rate In a dark day for MAHA, the FDA has approved Moderna’s mFLUSIVA for adults 50 and older, making it the first seasonal mRNA influenza injection authorized in the United States. Adults ages 50–64 received traditional approval, while adults 65 and older received accelerated approval based largely on antibody…